These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Some aspects of urinary kallikrein in a patient with Bartter's syndrome. Tamura Y; Matsuda Y; Yamada K; Takagi T; Nishikawa T; Watanabe M; Mikami K; Moriya H; Kumagai A Adv Exp Med Biol; 1979; 120B():515-24. PubMed ID: 517245 [No Abstract] [Full Text] [Related]
5. Effect of indomethacin on urinary kallikrein excretion in Bartter's syndrome of the adult. Lechi A; Mantero F; Opocher G; Armanini D; Lechi C; Covi G J Endocrinol Invest; 1981; 4(1):17-20. PubMed ID: 7016967 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of the kallikrein-kinin system and vascular reactivity in Bartter's syndrome. Rodriguez-Portales JA; Lopez-Moreno JM; Mahana D Hypertension; 1985; 7(6 Pt 1):1017-22. PubMed ID: 2416684 [TBL] [Abstract][Full Text] [Related]
7. Bartter's syndrome: effect of indomethacin on prostaglandins, urinary kallikrein, renin-angiotensin-aldosterone system, and the response to angiotensin II antagonist. Sasaki H; Kawasaki T; Okumura M; Asano T; Abe K; Arakawa K Endocrinol Jpn; 1980 Aug; 27(4):417-29. PubMed ID: 7007031 [No Abstract] [Full Text] [Related]
8. The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition. Vinci JM; Gill JR; Bowden RE; Pisano JJ; Izzo JL; Radfar N; Taylor AA; Zusman RM; Bartter FC; Keiser HR J Clin Invest; 1978 Jun; 61(6):1671-82. PubMed ID: 96139 [TBL] [Abstract][Full Text] [Related]
9. On the pathogenetic role of prostaglandins in Bartter's syndrome. Nielsen I; Hesse B; Christensen P Acta Med Scand Suppl; 1979; 625():135-40. PubMed ID: 285569 [TBL] [Abstract][Full Text] [Related]
10. The role of prostaglandins in Bartter's syndrome. Winterborn MH; Hewitt GJ; Mitchell MD Int J Pediatr Nephrol; 1984 Mar; 5(1):31-8. PubMed ID: 6370882 [TBL] [Abstract][Full Text] [Related]
11. Aldosterone and other mineralocorticoids in Bartter's syndrome. Saruta T; Fujimaki M; Senba S; Saito I; Konishi K J Lab Clin Med; 1984 Jun; 103(6):848-53. PubMed ID: 6373989 [TBL] [Abstract][Full Text] [Related]
12. Bartter's syndrome with normal urinary excretion of prostaglandin E: therapeutic effects of propranolol, spironolactone, indomethacin and potassium chloride. Sato M; Abe K; Yasujima M; Otsuka Y; Chiba S; Haruyama T; Yoshinaga K; Saito T; Kabuki J Tohoku J Exp Med; 1980 Jun; 131(2):151-9. PubMed ID: 7404582 [TBL] [Abstract][Full Text] [Related]
13. Excretion of human urinary kallikrein quantity measured by a direct radioimmunoassay of human urinary kallikrein in patients with essential hypertension and secondary hypertensive diseases. Shimamoto K; Ura N; Tanaka S; Ogasawara A; Nakao T; Nakahashi Y; Chao J; Margolius HS; Iimura O Jpn Circ J; 1981 Sep; 45(9):1092-7. PubMed ID: 6913609 [TBL] [Abstract][Full Text] [Related]
14. Bartter's syndrome results from an imbalance of vasoactive hormones. McGiff JC Ann Intern Med; 1977 Sep; 87(3):369-72. PubMed ID: 900681 [TBL] [Abstract][Full Text] [Related]
15. Effect of indomethacin upon the renin--angiotensin system in patients with Bartter's syndrome. Vierhapper H; Waldhäusl W Eur J Clin Invest; 1980 Apr; 10(2 Pt 1):119-24. PubMed ID: 6780358 [TBL] [Abstract][Full Text] [Related]
17. Role of prostaglandins in the pathogenesis of Bartter's syndrome. Fichman MP; Telfer N; Zia P; Speckart P; Golub M; Rude R Am J Med; 1976 May; 60(6):785-97. PubMed ID: 798488 [TBL] [Abstract][Full Text] [Related]
19. The effect of amiloride on the renin-aldosterone system in primary hyperaldosteronism and Bartter's syndrome. Griffing GT; Aurecchia SA; Sindler BH; Melby JC J Clin Pharmacol; 1982; 22(11-12):505-12. PubMed ID: 6761369 [TBL] [Abstract][Full Text] [Related]